Results 241 to 250 of about 127,271 (293)

Metalloids: Semi as Metals yet Full of Antimicrobial Potential

open access: yesChemMedChem, Volume 21, Issue 7, 14 April 2026.
Metalloids such as boron (B), silicon (Si), germanium (Ge), arsenic (As), antimony (Sb), and tellurium (Te) bridge metals and non‐metals, displaying unique chemical versatility. Recent research highlights their diverse antimicrobial and therapeutic potentials, from natural products to synthetic organic and organometallic molcules, underscoring renewed ...
Kevin Böhm   +2 more
wiley   +1 more source

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 14, 10 April 2026.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

Unlocking the Full Potential of Zinc Oxide/Cerium Oxide Composite Nanoparticles for Removal of Mixed Pharmaceutical and Dye Pollutants in Water

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 8, 21 April 2026.
ZnO/CeO2 composite nanoparticles synthesized via a facile hydrothermal method simultaneously degrade ciprofloxacin, tetracycline, methylene blue, and methyl orange in a four‐component mixture under UV irradiation. The Ce3+/Ce4+ redox cycling and oxygen vacancies at the ZnO/CeO2 interface suppress charge recombination and enhance reactive species ...
Aditya Rianjanu   +11 more
wiley   +1 more source

Ciprofloxacin

Drug Intelligence & Clinical Pharmacy, 1987
Ciprofloxacin is a new fluorinated quinolone antibiotic with high activity against a wide spectrum of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide ...
D K, Terp, M J, Rybak
openaire   +2 more sources

Ciprofloxacin

International Journal of Antimicrobial Agents, 1991
  +5 more sources

CIPROFLOXACIN RESISTANCE

The Lancet, 1987
B, Salh, A K, Webb
openaire   +2 more sources

Ciprofloxacin desensitization

Journal of Allergy and Clinical Immunology, 1996
J C, Gea-Banacloche, D D, Metcalfe
openaire   +2 more sources

Ciprofloxacin frenzy

American Journal of Health-System Pharmacy, 2001
S G, Smith, M S, Farber
openaire   +2 more sources

Home - About - Disclaimer - Privacy